Time Medical International Ventures (India) Private Limited, a wholly owned subsidiary of Fischer Medical Ventures Limited, has made a groundbreaking achievement by becoming the first indigenous MRI manufacturer in India to receive the official License to Manufacture for Sale or Distribution of Magnetic Resonance Diagnostic Devices (MRDD) from the Central Drugs Standard Control Organization (CDSCO).
This milestone is a significant step forward for the Make in India initiative and underscores the company’s commitment to producing high-quality, locally manufactured medical devices that meet stringent international standards.
With this new license, Time Medical is poised to manufacture and distribute advanced MRI systems across India. The company’s product lineup includes the EMMA, MICA, and QUIN MRI systems, all of which are 1.5T MRI scanners that offer exceptional imaging resolution and precision for a wide range of clinical applications. Additionally, the PICA model, a 0.35T MRI scanner, is tailored for specific diagnostic needs. These systems are FDA and CE-approved, ensuring that they meet global safety, quality, and regulatory standards.
The company stated that this achievement not only supports the growing demand for reliable and advanced medical imaging solutions in India but also aligns with Fischer Medical Ventures’ dedication to enhancing diagnostic capabilities and improving healthcare delivery across the country.
Commenting on this development, the Management Team of Fischer Medical Ventures, said, “We are thrilled to be the first Make in India company to receive the CDSCO license for the manufacturing and distribution of MRI systems. This achievement demonstrates the strength and potential of India’s medical device manufacturing sector. With our EMMA, PICA, MICA, and QUIN MRI systems, we are committed to providing hospitals and diagnostic centres with cutting-edge, affordable diagnostic imaging solutions.”
On January 14, 2025, Fischer Medical Ventures share price opened at ₹703.20, touching the day’s high at ₹730.00, as of 1:01 PM on the NSE.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jan 14, 2025, 2:43 PM IST
Nikitha Devi
Nikitha is a content creator with 6+ years of experience in the financial domain. Specialising in personal finance, investments, and market insights, Nikitha simplifies complex financial topics, making them accessible to readers.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates